Skip to main content

and
  1. Article

    Open Access

    Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life

    Idiopathic pulmonary fibrosis (IPF) is a chronic disease with a high symptom burden and poor survival that influences patients’ health-related quality of life (HRQOL). We aimed to evaluate IPF patients’ sympto...

    K. Rajala, J. T. Lehto, E. Sutinen, H. Kautiainen, M. Myllärniemi in BMC Pulmonary Medicine (2018)

  2. Article

    Open Access

    End-of-life care of patients with idiopathic pulmonary fibrosis

    Idiopathic pulmonary fibrosis (IPF) is a progressive disease with median survival from 2 to 7 years. Palliative care is an important part of patients´ care as lung transplantation is not an option for the majo...

    Kaisa Rajala, Juho T. Lehto, M. Saarinen, E. Sutinen, T. Saarto in BMC Palliative Care (2016)

  3. Article

    Open Access

    Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis

    The FinnishIPF registry is a prospective, longitudinal national registry study on the epidemiology of idiopathic pulmonary fibrosis (IPF). It was designed to describe the characteristics, management and progno...

    Jaana Kaunisto, K. Kelloniemi, E. Sutinen, U. Hodgson in BMC Pulmonary Medicine (2015)

  4. Article

    Open Access

    Gremlin-1 associates with fibrillin microfibrils in vivo and regulates mesothelioma cell survival through transcription factor slug

    Malignant mesothelioma is a form of cancer that is highly resistant to conventional cancer therapy for which no major therapeutic advances have been introduced. Here, we identify gremlin-1, a known bone morpho...

    J A Tamminen, V Parviainen, M Rönty, A P Wohl, L Murray, S Joenväärä in Oncogenesis (2013)